Apricus Biosciences Inc $1.95

down -0.02


28/7/2014 04:00 PM  |  NASDAQ : APRI  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get APRI Trend Analysis - it has underperformed the S&P 500 by 29%

Partner Headlines

  1. Apricus Biosciences Announces National Phase Approval for Vitaros in Spain ...

    Benzinga
  2. Apricus Biosciences Announces National Phase Approval for Vitaros in Luxembourg

    Benzinga
  3. Earnings Scheduled For March 17, 2014

    Benzinga
  4. Apricus Expands Exclusive License Agreement With Sandoz Affiliate, Apricus ...

    Benzinga
  5. Apricus Elects Kleanthis G. Xanthopoulos as New Chairman

    Benzinga
  6. Apricus Announces Laboratoires Majorelle to Market Vitaros in France, Monaco ...

    Benzinga
  7. Apricus Reports National Phase Approval of ED Cream in Germany

    Benzinga
  8. UPDATE: Cantor Fitzgerald Initiates Coverage on Apricus Biosciences on ...

    Benzinga
  9. Benzinga's Top Initiations

    Benzinga
  10. Apricus Biosciences Reports Vitaros National Phase Approvals in UK, Sweden

    Benzinga
  11. Apricus Biosciences Reports on Corporate Goals for 2013

    Benzinga
  12. Apricus Biosciences Receives $2.5M Payment From Abbott Laboratories

    Benzinga
  13. Benzinga's Top Pre-Market Gainers

    Benzinga
  14. Apricus Biosciences Announces Intent to File NDS for MycoVa in Canada

    Benzinga
  15. A Peek Into The Market Before The Trading Starts

    Benzinga
  16. Apricus Biosciences Subsidiary NexMed and Takeda Pharmaceuticals Sign ...

    Benzinga
  17. Apricus Biosciences Issues Statement Regarding Registration of Shares Related ...

    Benzinga
  18. Select Comfort, Mitcham Industries Among Stocks Down on Above-average Volume ...

    FoxBusiness
  19. Apricus Bioscience, Quepasa Corporation Among Stocks setting 52-Week Lows ...

    FoxBusiness
  20. Apricus Biosciences Strengthens Vitaros and Nexact Patent Estate With Two ...

    Benzinga
  21. Apricus Biosciences Granted Regulatory Meeting With FDA for Femprox(R) ...

    Benzinga
  22. Health Canada Grants Apricus Biosciences Pre-NDS Meeting for MycoVa(TM) ...

    Benzinga
  23. Apricus Bioscience's Wholly-Owned Subsidiary NexMed Signs Exclusive German ...

    Benzinga
  24. Apricus Biosciences and Elis Pharma Sign License Agreement for MycoVa in ...

    Benzinga
  25. Apricus Biosciences and Abbott Sign Exclusive Agreement to Market Vitaros ...

    Benzinga
  26. Apricus Biosciences and Stellar Pharmaceuticals Announce Exclusive License ...

    Benzinga
  27. Apricus Biosciences Enters into Exclusive License Agreement with Stellar ...

    Benzinga
  28. Apricus Biosciences Announces Allowance of Additional NexACT Patent in ...

    Benzinga
Trading Center